Evaluation of a selective colistin susceptibility testing practice and identification of antimicrobial resistance indicators associated with the need for colistin testing.

Abstract The development of multidrug-resistant (MDR) pathogens has renewed the clinical significance of colistin as a last-line antibacterial drug. However, colistin susceptibility testing (CST) is often selectively caried out, and the antimicrobial resistance features associated with test selection remain unsuccessfully defined. This retrospective case study evaluated selective CST practices in routine clinical microbiology at a governmental medical city. Associations between colistin-test selection and bacterial groups, MDR status, and individual antimicrobial resistance patterns were assessed using exact statistical tests, odds ratios, relative risks, and Phi coefficients. Hierarchical clustering and biochemical profiling were additionally performed for colistin-tested resistant isolates. Only 19 isolates underwent CST, all of which were MDR and resistant to colistin. Enterobacterales were meaningfully more likely to be selected for testing than other bacterial groups. Test selection was strongly associated with MDR status and resistance to several clinically important antimicrobial agents, particularly carbapenems, as well as aminoglycosides, fluoroquinolones, and piperacillin/tazobactam, whereas cephalosporin resistance showed no significant association. Resistance clustering revealed substantial phenotypic heterogeneity, while biochemical profiling identified conserved characteristics despite taxonomic diversity. These findings suggest that MDR and carbapenem resistance may serve as practical indicators for considering CST. However, because colistin susceptibility was unknown for non-tested isolates, these factors should not be interpreted as predictors of colistin resistance itself. Multicenter validation is warranted to support the development of standardized, risk-based colistin-testing strategies. The present study nevertheless provides important practice-based evidence and an exploratory framework for designing larger multicenter studies.

Authors

Institutions

Publication Details

Journal
Research Square
Published
2026-11-13
DOI
https://doi.org/10.21203/rs.3.rs-11201132/v1
Primary Topic
Antibiotic Resistance in Bacteria
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Evaluation of a selective colistin susceptibility testing practice and identification of antimicrobial resistance indicators associated with the need for colistin testing.

Jamal Mohammed Ali Khaled, Naiyf Alharbi, Raed Al-Hababi, MOHAMMED ALMISHRAFI
Research Square
Antibiotic Resistance in Bacteria
preprint

Evaluation of a selective colistin susceptibility testing practice and identification of antimicrobial resistance indicators associated with the need for colistin testing.

Jamal Mohammed Ali Khaled, Naiyf Alharbi, Raed Al-Hababi, MOHAMMED ALMISHRAFI
preprint en

Abstract

Abstract The development of multidrug-resistant (MDR) pathogens has renewed the clinical significance of colistin as a last-line antibacterial drug. However, colistin susceptibility testing (CST) is often selectively caried out, and the antimicrobial resistance features associated with test selection remain unsuccessfully defined. This retrospective case study evaluated selective CST practices in routine clinical microbiology at a governmental medical city. Associations between colistin-test selection and bacterial groups, MDR status, and individual antimicrobial resistance patterns were assessed using exact statistical tests, odds ratios, relative risks, and Phi coefficients. Hierarchical clustering and biochemical profiling were additionally performed for colistin-tested resistant isolates. Only 19 isolates underwent CST, all of which were MDR and resistant to colistin. Enterobacterales were meaningfully more likely to be selected for testing than other bacterial groups. Test selection was strongly associated with MDR status and resistance to several clinically important antimicrobial agents, particularly carbapenems, as well as aminoglycosides, fluoroquinolones, and piperacillin/tazobactam, whereas cephalosporin resistance showed no significant association. Resistance clustering revealed substantial phenotypic heterogeneity, while biochemical profiling identified conserved characteristics despite taxonomic diversity. These findings suggest that MDR and carbapenem resistance may serve as practical indicators for considering CST. However, because colistin susceptibility was unknown for non-tested isolates, these factors should not be interpreted as predictors of colistin resistance itself. Multicenter validation is warranted to support the development of standardized, risk-based colistin-testing strategies. The present study nevertheless provides important practice-based evidence and an exploratory framework for designing larger multicenter studies.

Research Square
King Saud Medical City (SA), King Saud University (SA)
Good health and well-being
Antibiotic Resistance in Bacteria
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon